Cancer patients are willing to experiment, try alternatives: Tom Brazaitis

Conventional medicine has little to offer kidney cancer patients. Interleukin-2, the so-called gold standard of treatment, cures only 6 to 8 percent of patients. Given that kind of success rate, the siren song of alternative treatments is hard to …
See all stories on this topic »